Dick L. Sherman

Dick L. Sherman

Segretario Aziendale presso TETRALOGIC PHARMACEUTICALS CORPORATION

76 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Dick Sherman is a Venture Partner with SCP focusing on the life sciences area.
Prior to joining SCP, he spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline) and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life science business consulting firm that is now a wholly-owned subsidiary of The Omnicom Group in New York.
Dick has served on the Board of Directors of CytoMed, Inc., IBAH, Inc., Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta Pharmaceuticals.
He also serves as Secretary and General Counsel of Hawaii Biotech, Inc., acts as a consultant to the law firm of Goodsill Anderson Quinn & Stifel, in Honolulu, and is a principal in CIP Capital, L.P.
Dick is involved in a broad range of life sciences industry activities.
He is a Venture Partner of Ventana Global, a venture fund located in Irvine, California, serves as Chairman of Directors at Biophage, Inc., and is a board member of the Sbarro Research Organization.
He is also on the Technology Advisory Board for The Children's Hospital of Philadelphia and is a member of the Advisory Board of the University of Hawaii Medical School.
Dick graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa.
He received his J.D.
from New York University School of Law in 1971 as a Root-Tilden Scholar.
Dick is involved in a broad range of life sciences industry activities.
He is a Venture Partner of Ventana Global, a venture fund located in Irvine, California, serves as Chairman of Directors at Biophage, Inc., and is a board member of the Sbarro Research Organization.
He is also on the Technology Advisory Board for The Children's Hospital of Philadelphia and is a member of the Advisory Board of the University of Hawaii Medical School.
Dick graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa.

Posizioni attive di Dick L. Sherman

SocietàPosizioneInizio
TETRALOGIC PHARMACEUTICALS CORPORATION Segretario Aziendale 01/11/2012
Investitore di Private Equity -
Amministratore Delegato 07/06/2021
Tutte le posizioni attive di Dick L. Sherman

Precedenti posizioni note di Dick L. Sherman

SocietàPosizioneFine
IMMUNOMEDICS, INC. Direttore/Membro del Consiglio 02/12/2015
FUNCTIONAL TECHNOLOGIES CORP Presidente 25/06/2013
Consigliere Generale 18/04/2013
Direttore/Membro del Consiglio 01/02/2013
Fondatore 01/01/2001
Vedi nel dettaglio l'esperienza di Dick L. Sherman

Formazione di Dick L. Sherman

University of Nebraska Undergraduate Degree
New York University Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Dick L. Sherman

Relazioni

100 +

Relazioni di 1° grado

21

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
MERA PHARMACEUTICALS, INC.

Health Technology

TETRALOGIC PHARMACEUTICALS CORPORATION

Health Technology

Aziende private17

Health Technology

Health Technology

IBAH, Inc.

Commercial Services

Finance

Health Technology

Consumer Non-Durables

Health Technology

Commercial Services

Commercial Services

Health Services

Health Technology

Commercial Services

Health Technology

Technology Services

Commercial Services

Finance

Commercial Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Dick L. Sherman